Antibody, In Vivo Mab

anti-PCSK9 (Alirocumab)

  • Catalog Number : A510011
  • Number : A510011-1mg
  • Size:
    Qty :
  • Price : Request Inquiry
  • Download DataSheet print

Introduction

Alirocumab biosimilar is a human monoclonal antibody (IgG1 isotype) that targets proprotein convertase subtilisin kexin type 9 (PCSK9), is a PCSK9 inhibitor produced by recombinant DNA technology in Chinese Hamster Ovary cell suspension culture. Alirocumab biosimilar consists of two disulfide-linked human heavy chains, each covalently linked through a disulfide bond to a human kappa light chain. A single Nlinked glycosylation site is located in each heavy chain within the CH2 domain of the Fc constant region of the molecule. The variable domains of the heavy and light chains combine to form the PCSK9 binding site within the antibody. Alirocumab biosimilar has an approximate molecular weight of 146 kDa.

General Information

Reactivity Human
Application Functional Assay
Host CHO cells
Clonality Monoclonal
Conjugate Non-conjugated
Isotype Human IgG1
Cas No. 1245916-14-6
Purity >95%; < 0.75 EU/mg as determined by the LAL method
Molecular Weight 146 kDa
Storage buffer 0.01 M phosphate buffered saline (PBS) pH 7.2
Storage instruction This solution is stable for at least 4 weeks when stored at 2-8°C. For long term storage aseptically aliquot and store at –80°C.Avoid repeated freeze/thaw cycles.

Recently Viewed Products

gotop link
Customized Product Contact Us
0